TrustCore Financial Services’s Meridian Bioscience Inc VIVO Stock Holding History

TrustCore Financial Services’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$9.96K	Hold	300	–	–	﹤0.01%	722
2022 Q3	$9K	Hold	300	–	–	﹤0.01%	775
2022 Q2	$9K	Hold	300	–	–	﹤0.01%	767
2022 Q1	$8K	Buy	+300	New	+$7.14K	﹤0.01%	807
2021 Q4	–	Sell	-300	Closed	-$6K	–	1085
2021 Q3	$6K	Hold	300	–	–	﹤0.01%	856
2021 Q2	$7K	Hold	300	–	–	﹤0.01%	810
2021 Q1	$8K	Hold	300	–	–	﹤0.01%	737
2020 Q4	$6K	Hold	300	–	–	﹤0.01%	756
2020 Q3	$5K	Hold	300	–	–	﹤0.01%	704
2020 Q2	$7K	Hold	300	–	–	﹤0.01%	680
2020 Q1	$3K	Hold	300	–	–	﹤0.01%	755
2019 Q4	$3K	Hold	300	–	–	﹤0.01%	808
2019 Q3	$3K	Sell	300 -250	-45%	-$2.63K	﹤0.01%	834
2019 Q2	$7K	Hold	550	–	–	﹤0.01%	693
2019 Q1	$10K	Buy	+550	New	+$9.15K	﹤0.01%	575
2018 Q4	–	Sell	-550	Closed	-$8K	–	833
2018 Q3	$8K	Hold	550	–	–	﹤0.01%	616
2018 Q2	$9K	Hold	550	–	–	﹤0.01%	589
2018 Q1	$8K	Hold	550	–	–	﹤0.01%	543
2017 Q4	$8K	Buy	+550	New	+$8.05K	﹤0.01%	524

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TrustCore Financial Services's VIVO Position: Q4 2022 in Review

TrustCore Financial Services held its Meridian Bioscience Inc (VIVO) position steady in Q4 2022 at 300 shares worth $9.96K. The position accounts for ﹤0.01% of the portfolio, ranked #722.

TrustCore Financial Services first reported a position in VIVO in Q4 2017 and has held it in 19 quarters since. The position peaked at $10K in Q1 2019. 218 funds tracked by Wall St. Rank hold VIVO as of Q4 2022.

TrustCore Financial Services held 300 shares of Meridian Bioscience Inc worth $9.96K as of Q4 2022.
TrustCore Financial Services left its Meridian Bioscience Inc share count unchanged in Q4 2022.
Meridian Bioscience Inc made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #722 holding.
TrustCore Financial Services first reported a position in Meridian Bioscience Inc in Q4 2017 and has held it in 19 quarters since.
TrustCore Financial Services's Meridian Bioscience Inc position peaked at $10K in Q1 2019.
218 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.